AST-NS2301

N/A

Report date: 2023/12/26 14:59:56
NME

Base Information

Drug NameAST-NS2301
Drug Alias NameAST-NS2301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase inhibitors
TargetsMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Allist Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Allist Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A